ASMB - Company ID 0001426800
The table below shows ASSEMBLY BIOSCIENCES, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $13.37M | $8.21M | $10.79M | $9.63M | $9.42M | $6.84M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $14.92M | $14.90M | $16.59M | $16.13M | $14.85M | $13.52M |
ASSEMBLY BIOSCIENCES, INC. reported annual revenue of $72.30M for fiscal year 2025. That is up 153.5% from $28.52M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $4.80M |
| $4.68M |
| $5.08M |
| $4.59M |
| $4.51M |
| $4.29M |
| Operating income | -$6.34M | -$11.37M | -$10.88M | -$11.09M | -$9.94M | -$10.96M |
| Income tax | - | - | $0.00 | $0.00 | - | $0.00 |
| Net income | -$3.86M | -$9.08M | -$9.20M | -$10.20M | -$8.82M | -$9.61M |
| EPS (diluted) | -$0.20 | -$0.54 | -$0.72 | -$1.33 | -$1.17 | -$1.51 |